Pubblicazioni Scientifiche
Dermatologia17 lug 2023
Interleukin-17 pathway inhibition with brodalumab in early systemic sclerosis
Analysis of a single-arm, open-label, phase 1 trial
17 lug 2023
Physical urticaria
Physical urticaria is a type of urticaria in which recurrent wheals and/or angioedema occur following exposure of the skin to a physical stimulus
03 lug 2023
Prevalence and Implications of Mogamulizumab-induced Immune
Prevalence and Implications of Mogamulizumab-induced Immune
03 lug 2023
Primary Cutaneous B-Cell Lymphomas
Most primary cutaneous lymphomas consist of T-cell lymphomas or small cell lymphomas
03 lug 2023
Abrocitinib efficacy and safety in patients
Abrocitinib improved signs and symptoms of moderate-to-severe atopic dermatitis (AD) at 12/16 weeks in phase 3 studies with a manageable safety profile
13 giu 2023
Combatting antifungal resistance
Antifungal resistance has become prevalent worldwide. Understanding the factors involved in spread of resistance allows the formulation of strategies to slow resistance
13 giu 2023
Impact and Management of Loss of Eyebrows
Eyelashes and eyebrows have different functions, ranging from practical purposes such as protecting the eye apparatus from external hazards
13 giu 2023
Melanoma in children
The current evidence on paediatric melanoma is heterogeneous, especially regarding the prognosis of different histological subtypes.
05 giu 2023
Definition of the Clinical Characteristics of Patients with Moderate and Severe Atopic Dermatitis
Narrow-band (NB) UVB and UVA1 have been successfully used for the treatment of atopic dermatitis (AD) since the 1980s
05 giu 2023
Cosmetic Procedures in Patients with Skin of Color
Over time, cosmetic procedures have continued to grow in popularity and patients
05 giu 2023
Oral orismilast
Orismilast is a high-potency phosphodiesterase 4 (PDE4) inhibitor with enhanced selectivity for the PDE4B and PDE4D subtypes
22 mag 2023
An update on Epstein-Barr virus-and human T-lymphotropic virus
The Epstein-Barr virus (EBV) is a DNA virus that infects 90% of the human population
22 mag 2023
An update on viral-induced cutaneous
Viral-induced cutaneous T-cell lymphomas are an uncommon group of lymphoproliferative disorders characterized by a viral infection
22 mag 2023
Clinical management of melanocytic tumours
Little guidance is currently available for managing patients with melanocytic tumours
04 mag 2023
Quality of life measurement in rosacea
The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient-Oriented Outcomes and Acne
04 mag 2023
Criteria used to define tumor
Determining tumor necrosis factor-alpha inhibitors (anti-TNF-α) failure is still a challenge in the management of moderate-to-severe
04 mag 2023
Efficacy and safety of abrocitinib monotherapy in adolescents and adults
Differences in atopic dermatitis (AD) disease course and manifestation with age may extend to treatment response
17 apr 2023
Bimekizumab maintenance of response through three years
Given the chronic nature of psoriasis and the loss of response that can be observed with therapies over time
17 apr 2023
Multidisciplinary Approach to the Diagnosis
Mycosis fungoides is the most common primary cutaneous T-cell lymphoma
17 apr 2023
The impact of dupilumab
Skin barrier dysfunction plays an important role in atopic dermatitis (AD) aetiopathogenesis